ANZICS CTG Endorsed Study

TARGET PPP (NZ) / Nutrition prescription in ANZ: PPD (AUS)

TARGET Point Prevalence Study – New Zealand OR Nutrition prescription in Australian and New Zealand intensive care units: A point prevalence audit – Australia

Study Description

The Augmented versus Routine approach to Giving Energy Trial (TARGET) was a 4000-patient randomised controlled, multicentre trial comparing augmented enteral energy delivery to standard care on 90-day survival. TARGET completed recruitment in November 2017. In order to evaluate the influence TARGET has had on current practice and may have on future practice, an understanding of current nutrition practices in Australian and New Zealand intensive care units (ICUs) must be obtained. Data on protein prescription will also guide a Phase III trial on protein delivery in critically ill adults.

This is a prospective, observational, multicentre, single-day, point-prevalence study. The objective is to determine common nutrition (energy and protein) prescriptions across Australia and New Zealand ICUs.

Management Committee

A/Prof Lee-anne Chapple (PI), Dr Anneleen Neuts, Prof Marianne Chapman, Prof Sandra Peake, Stephanie O’Connor (PM [AUS]), Patricia Williams, Sally Hurford, A/ Prof Andrew Davies, Donna Goldsmith, Sue Huckson, Ms Lorraine Little (PM-NZ), A/Prof John Moran

Administering Institution

Central Adelaide Local Health Network

Sample Size

600 patients






Lee-anne Chapple (email)

Stephanie O’Connor (email)